Hologic - News Releases http://investors.hologic.com/ New USPSTF Draft Cervical Cancer Screening Recommendations Are a Step Back for Women's Health, Would Put Lives at Risk http://investors.hologic.com/2017-09-14-New-USPSTF-Draft-Cervical-Cancer-Screening-Recommendations-Are-a-Step-Back-for-Womens-Health-Would-Put-Lives-at-Risk Thu, 14 Sep 2017 08:12:00 -0400 http://investors.hologic.com/2017-09-14-New-USPSTF-Draft-Cervical-Cancer-Screening-Recommendations-Are-a-Step-Back-for-Womens-Health-Would-Put-Lives-at-Risk Hologic’s 3Dimensions™ Mammography System Now Available in Europe http://investors.hologic.com/3Dimensions --Fastest, Highest Resolution Breast Tomosynthesis System is Designed to Increase Clinical Confidence, Accuracy and Patient Comfort-- Mon, 11 Sep 2017 08:00:00 -0400 http://investors.hologic.com/3Dimensions Hologic Announces Availability of New Brevera® Breast Biopsy System with CorLumina® Imaging Technology http://investors.hologic.com/2017-08-31-Hologic-Announces-Availability-of-New-Brevera-R-Breast-Biopsy-System-with-CorLumina-R-Imaging-Technology Transformational Workflow Solution Offers Real-Time Imaging of Tissue Samples, Resulting in Major Cost and Time Savings Thu, 31 Aug 2017 08:00:00 -0400 http://investors.hologic.com/2017-08-31-Hologic-Announces-Availability-of-New-Brevera-R-Breast-Biopsy-System-with-CorLumina-R-Imaging-Technology Hologic Announces Financial Results for Third Quarter of Fiscal 2017 http://investors.hologic.com/2017-08-02-Hologic-Announces-Financial-Results-for-Third-Quarter-of-Fiscal-2017 -- Company Posts Revenue of $806.1 Million, GAAP Diluted EPS of $0.21, and Non-GAAP Diluted EPS of $0.50 -- Wed, 02 Aug 2017 16:01:00 -0400 http://investors.hologic.com/2017-08-02-Hologic-Announces-Financial-Results-for-Third-Quarter-of-Fiscal-2017 Hologic to Webcast Presentations at Upcoming Investor Conferences http://investors.hologic.com/2017-07-31-Hologic-to-Webcast-Presentations-at-Upcoming-Investor-Conferences Mon, 31 Jul 2017 16:01:00 -0400 http://investors.hologic.com/2017-07-31-Hologic-to-Webcast-Presentations-at-Upcoming-Investor-Conferences Hologic to Announce Financial Results for the Third Quarter of Fiscal 2017 on Wednesday, August 2, 2017 http://investors.hologic.com/2017-07-05-Hologic-to-Announce-Financial-Results-for-the-Third-Quarter-of-Fiscal-2017-on-Wednesday-August-2-2017 Wed, 05 Jul 2017 16:01:00 -0400 http://investors.hologic.com/2017-07-05-Hologic-to-Announce-Financial-Results-for-the-Third-Quarter-of-Fiscal-2017-on-Wednesday-August-2-2017 Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2042 are Eligible to Convert http://investors.hologic.com/2017-07-03-Hologic-Delivers-Notice-that-Holders-of-2-00-Convertible-Exchange-Senior-Notes-Due-2042-are-Eligible-to-Convert Mon, 03 Jul 2017 13:00:00 -0400 http://investors.hologic.com/2017-07-03-Hologic-Delivers-Notice-that-Holders-of-2-00-Convertible-Exchange-Senior-Notes-Due-2042-are-Eligible-to-Convert Hologic's New Panther Fusion® System, Flu and Respiratory Assays Now CE Marked in Europe http://investors.hologic.com/2017-06-29-Hologics-New-Panther-Fusion-R-System-Flu-and-Respiratory-Assays-Now-CE-Marked-in-Europe -- New Panther Fusion® Module Expands Molecular Testing Capabilities, Increases Productivity and Flexibility for the Laboratory Thu, 29 Jun 2017 08:00:00 -0400 http://investors.hologic.com/2017-06-29-Hologics-New-Panther-Fusion-R-System-Flu-and-Respiratory-Assays-Now-CE-Marked-in-Europe Hologic Receives Additional CE-Marked Claims for Aptima® Combo 2® Assay for Chlamydia Trachomatis and Neisseria Gonorrhoeae in Europe http://investors.hologic.com/news?item=654 --Assay Now Cleared for Throat and Rectal Specimens for Use on the Panther System-- Tue, 20 Jun 2017 10:30:00 -0400 http://investors.hologic.com/news?item=654 Hologic Announces FDA Clearance of Aptima® Assay to Detect Herpes Simplex Virus 1 & 2 http://investors.hologic.com/2017-06-20-Hologic-Announces-FDA-Clearance-of-Aptima-R-Assay-to-Detect-Herpes-Simplex-Virus-1-2 -- Aptima HSV 1 & 2 Assay Now Available Alongside Women's Health, Virology Menu on the Fully Automated Panther System -- Tue, 20 Jun 2017 08:00:00 -0400 http://investors.hologic.com/2017-06-20-Hologic-Announces-FDA-Clearance-of-Aptima-R-Assay-to-Detect-Herpes-Simplex-Virus-1-2 Hologic Receives Expanded FDA 510(k) Clearance to Market Cynosure's SculpSure® for Non-Invasive Body Contouring (Lipolysis) of Back, Inner and Outer Thighs http://investors.hologic.com/2017-06-15-Hologic-Receives-Expanded-FDA-510-k-Clearance-to-Market-Cynosures-SculpSure-R-for-Non-Invasive-Body-Contouring-Lipolysis-of-Back-Inner-and-Outer-Thighs SculpSure Now Cleared to Treat Five Areas of the Body Thu, 15 Jun 2017 08:00:00 -0400 http://investors.hologic.com/2017-06-15-Hologic-Receives-Expanded-FDA-510-k-Clearance-to-Market-Cynosures-SculpSure-R-for-Non-Invasive-Body-Contouring-Lipolysis-of-Back-Inner-and-Outer-Thighs FDA Approves Hologic's Genius™ 3D Mammography™ Exam as the Only Mammogram Superior for Women with Dense Breasts* http://investors.hologic.com/2017-06-07-FDA-Approves-Hologics-Genius-TM-3D-Mammography-TM-Exam-as-the-Only-Mammogram-Superior-for-Women-with-Dense-Breasts --Genius exam improves cancer detection and reduces recall rates for women of all ages and breast types, including the nearly 50 percent of women of breast cancer screening age who have dense breasts-- Wed, 07 Jun 2017 08:00:00 -0400 http://investors.hologic.com/2017-06-07-FDA-Approves-Hologics-Genius-TM-3D-Mammography-TM-Exam-as-the-Only-Mammogram-Superior-for-Women-with-Dense-Breasts Charles J. Dockendorff Elected to Hologic Board of Directors http://investors.hologic.com/2017-05-16-Charles-J-Dockendorff-Elected-to-Hologic-Board-of-Directors Tue, 16 May 2017 16:01:00 -0400 http://investors.hologic.com/2017-05-16-Charles-J-Dockendorff-Elected-to-Hologic-Board-of-Directors Hologic Announces Financial Results for Second Quarter of Fiscal 2017 http://investors.hologic.com/2017-05-10-Hologic-Announces-Financial-Results-for-Second-Quarter-of-Fiscal-2017 -- GAAP Diluted EPS of $1.84 Increases 666.7%, Non-GAAP Diluted EPS of $0.50 Increases 6.4% -- Wed, 10 May 2017 16:03:00 -0400 http://investors.hologic.com/2017-05-10-Hologic-Announces-Financial-Results-for-Second-Quarter-of-Fiscal-2017 Hologic to Webcast Presentations at Upcoming Investor Conferences http://investors.hologic.com/2017-05-08-Hologic-to-Webcast-Presentations-at-Upcoming-Investor-Conferences Mon, 08 May 2017 16:01:00 -0400 http://investors.hologic.com/2017-05-08-Hologic-to-Webcast-Presentations-at-Upcoming-Investor-Conferences Hologic to Announce Financial Results for the Second Quarter of Fiscal 2017 on Wednesday, May 10, 2017 http://investors.hologic.com/2017-04-04-Hologic-to-Announce-Financial-Results-for-the-Second-Quarter-of-Fiscal-2017-on-Wednesday-May-10-2017 Tue, 04 Apr 2017 16:01:00 -0400 http://investors.hologic.com/2017-04-04-Hologic-to-Announce-Financial-Results-for-the-Second-Quarter-of-Fiscal-2017-on-Wednesday-May-10-2017 Hologic Delivers Notice that Holders of 2.00% Convertible Exchange Senior Notes Due 2042 are Eligible to Convert http://investors.hologic.com/2017-04-03-Hologic-Delivers-Notice-that-Holders-of-2-00-Convertible-Exchange-Senior-Notes-Due-2042-are-Eligible-to-Convert Mon, 03 Apr 2017 16:01:00 -0400 http://investors.hologic.com/2017-04-03-Hologic-Delivers-Notice-that-Holders-of-2-00-Convertible-Exchange-Senior-Notes-Due-2042-are-Eligible-to-Convert Hologic Completes Acquisition of Cynosure http://investors.hologic.com/2017-03-22-Hologic-Completes-Acquisition-of-Cynosure -- Transaction Provides Entry into Large, Fast-Growing Medical Aesthetics Market, Boosts Hologic's Growth Rate -- Wed, 22 Mar 2017 09:00:00 -0400 http://investors.hologic.com/2017-03-22-Hologic-Completes-Acquisition-of-Cynosure Hologic to Showcase Groundbreaking Breast Cancer Screening and Interventional Solutions at European Congress of Radiology 2017 http://investors.hologic.com/ECR2017 --Comprehensive suite of transformative products spotlights Hologic’s ongoing dedication to innovation and the advancement of breast health -- Wed, 01 Mar 2017 10:53:00 -0500 http://investors.hologic.com/ECR2017 FDA Grants PMA Approval for Hologic's Aptima® Hepatitis C Quant Dx Assay http://investors.hologic.com/2017-02-15-FDA-Grants-PMA-Approval-for-Hologics-Aptima-R-Hepatitis-C-Quant-Dx-Assay HCV viral load test now available alongside HIV-1 assay and women's health menu on the fully automated Panther system Wed, 15 Feb 2017 16:01:00 -0500 http://investors.hologic.com/2017-02-15-FDA-Grants-PMA-Approval-for-Hologics-Aptima-R-Hepatitis-C-Quant-Dx-Assay Hologic's Aptima® Zika Virus Assay Now CE Marked in Europe http://investors.hologic.com/news?item=641 --New Diagnostic Test Available for Use on the Panther System-- Tue, 14 Feb 2017 09:00:00 -0500 http://investors.hologic.com/news?item=641 Hologic to Acquire Cynosure, Leader in Medical Aesthetics Systems and Technologies, in All-Cash Tender Offer that Combines Two Complementary Businesses http://investors.hologic.com/2017-02-14-Hologic-to-Acquire-Cynosure-Leader-in-Medical-Aesthetics-Systems-and-Technologies-in-All-Cash-Tender-Offer-that-Combines-Two-Complementary-Businesses -Expands Hologic's Scientific and Commercial Expertise into Large, Adjacent Medical Device Segment Growing at Double-Digit Rate - Tue, 14 Feb 2017 08:00:00 -0500 http://investors.hologic.com/2017-02-14-Hologic-to-Acquire-Cynosure-Leader-in-Medical-Aesthetics-Systems-and-Technologies-in-All-Cash-Tender-Offer-that-Combines-Two-Complementary-Businesses Hologic to Webcast Presentations at Upcoming Investor Conferences http://investors.hologic.com/2017-02-09-Hologic-to-Webcast-Presentations-at-Upcoming-Investor-Conferences Thu, 09 Feb 2017 16:01:00 -0500 http://investors.hologic.com/2017-02-09-Hologic-to-Webcast-Presentations-at-Upcoming-Investor-Conferences Hologic Launches Next-Generation NovaSure® ADVANCED Global Endometrial Ablation System for the Treatment of Abnormal Uterine Bleeding http://investors.hologic.com/2017-02-02-Hologic-Launches-Next-Generation-NovaSure-R-ADVANCED-Global-Endometrial-Ablation-System-for-the-Treatment-of-Abnormal-Uterine-Bleeding --Smaller 6 mm Diameter and Product Updates Are Designed to Enhance Patient Comfort and Improve Physician Ease-of-Use-- Thu, 02 Feb 2017 08:00:00 -0500 http://investors.hologic.com/2017-02-02-Hologic-Launches-Next-Generation-NovaSure-R-ADVANCED-Global-Endometrial-Ablation-System-for-the-Treatment-of-Abnormal-Uterine-Bleeding Hologic Announces Financial Results for First Quarter of Fiscal 2017 http://investors.hologic.com/2017-02-01-Hologic-Announces-Financial-Results-for-First-Quarter-of-Fiscal-2017 -- GAAP Diluted EPS of $0.30 Increases 3.4%, Non-GAAP Diluted EPS of $0.52 Increases 13.0% -- Wed, 01 Feb 2017 16:01:00 -0500 http://investors.hologic.com/2017-02-01-Hologic-Announces-Financial-Results-for-First-Quarter-of-Fiscal-2017